InvestorsHub Logo
Followers 7
Posts 871
Boards Moderated 0
Alias Born 07/08/2013

Re: None

Tuesday, 01/28/2020 5:27:41 PM

Tuesday, January 28, 2020 5:27:41 PM

Post# of 73574
Has IR communicated with anyone who is on this board recently? Is it worth it to try to reach out to them for information? They cannot tell me anything that is not public knowledge due to fair disclosure laws.

I would like to know the status of the patent that is pending. I would like to know more about the Elixer CBD project. I would like to know more about our line of credit. What is the interest rate for example. We don’t hear many details about Prolayed. What sorts of sales figures can we expect for Vitastem , Prolayed and other products online and at Amazon?

There are many questions that an investor should have with VDRM because news flow from the company has been notably sparse for 18 months. We did get a blip of info 8 days ago from Dr, Otiko that he is behind the scenes and working hard for us, the shareholders. (Stock price more than doubled on that). We also see a 2020 add for Elixer mentioning Viaderma transdermal technology.

We need to know that the company is trying to stay current with the OTC reporting requirements. The Stop Sign is bad publicity. With a new line of credit this should be a priority to get done.

I think IR is allowed to say what they are doing and planning to get done if widely disseminated. In terms of complying with fair disclosure rules and any possible lawsuit it might be smartest and easiest to say nothing at all to investors.